Details for Patent: 8,573,209
✉ Email this page to a colleague
Which drugs does patent 8,573,209 protect, and when does it expire?
Patent 8,573,209 protects INOMAX and is included in one NDA.
Protection for INOMAX has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has twenty-four patent family members in thirteen countries.
Summary for Patent: 8,573,209
| Title: | Gas delivery device and system |
| Abstract: | A gas delivery system including a gas delivery device (100), a control module (200) and a gas delivery mechanism is described. An exemplary gas delivery device includes a valve (107) assembly with a valve and circuit including a memory (134), a processor (122) and a transceiver (120) in communication with the memory. The memory may include gas data such as gas identification, gas expiration and gas concentration. The transceiver on the circuit of the valve assembly may send wireless optical line-of-sight signals to communicate the gas data to a control module. Exemplary gas delivery mechanisms include a ventilator (400) and a breathing circuit (410). Methods of administering gas are also described. |
| Inventor(s): | Bathe; Duncan P. (Fitchburg, WI), Klaus; John (Cottage Grove, WI), Christensen; David (Cambridge, WI) |
| Assignee: | INO Therapeutics LLC (Hampton, NJ) |
| Application Number: | 13/509,873 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,573,209 |
|
Patent Claim Types: see list of patent claims | Delivery; Device; |
Drugs Protected by US Patent 8,573,209
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mallinckrodt Hosp | INOMAX | nitric oxide | GAS;INHALATION | 020845-002 | Dec 23, 1999 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | ||||
| Mallinckrodt Hosp | INOMAX | nitric oxide | GAS;INHALATION | 020845-003 | Dec 23, 1999 | AA | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,573,209
| PCT Information | |||
| PCT Filed | January 06, 2011 | PCT Application Number: | PCT/US2011/020319 |
| PCT Publication Date: | July 12, 2012 | PCT Publication Number: | WO2012/094008 |
International Family Members for US Patent 8,573,209
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011328891 | ⤷ Try a Trial | |||
| Australia | 2013257484 | ⤷ Try a Trial | |||
| Australia | 2015200792 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
